EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 178 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $12,363,000 | -47.5% | 156,717 | -44.8% | 0.88% | -48.4% |
| Q1 2017 | $23,551,000 | -2.5% | 283,954 | -6.7% | 1.71% | -0.3% |
| Q4 2016 | $24,144,000 | +10.3% | 304,305 | -2.7% | 1.71% | +9.2% |
| Q3 2016 | $21,886,000 | +45.0% | 312,655 | -19.7% | 1.57% | +68.5% |
| Q2 2016 | $15,095,000 | -7.8% | 389,155 | -3.7% | 0.93% | -7.2% |
| Q1 2016 | $16,368,000 | -54.9% | 404,155 | -1.2% | 1.00% | -53.1% |
| Q4 2015 | $36,258,000 | +14.4% | 408,915 | -4.5% | 2.14% | +19.7% |
| Q3 2015 | $31,707,000 | -14.0% | 428,295 | -6.1% | 1.79% | -0.6% |
| Q2 2015 | $36,866,000 | – | 455,925 | – | 1.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |